Cytokinetics ticker

WebFeb 15, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced topline results from METEORIC-HF ( M ulticenter E xercise T olerance E... WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential …

Cytokinetics, Incorporated (CYTK) - Stock Analysis

WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. WebApr 5, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … chromium nicotinate benefits https://nicoleandcompanyonline.com

Cytokinetics, Incorporated Common Stock (CYTK) - Nasdaq

WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- … Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance … Webwww.cytonics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology … chromium next gem single cell 3\u0027 kit

Cytokinetics - Funding, Financials, Valuation & Investors

Category:CYTK Stock Forecast, Price & News (Cytokinetics)

Tags:Cytokinetics ticker

Cytokinetics ticker

Cytokinetics - Crunchbase Company Profile & Funding

WebJul 19, 2024 · The data suggest that Cytokinetics (ticker: CYTK) drug could become a potent rival to a similar investigational drug that Bristol Myers Squibb (BMY) acquired last … WebNov 1, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2024 it granted stock options to purchase an aggregate...

Cytokinetics ticker

Did you know?

WebTicker: CYTK; CUSIP Number: 23282w605; Tip: Access positions for across all investors ... By clicking the button below, your credit card will be charged $28.00 USD (one time) and you'll have access to all Cytokinetics position data for 90 days. Purchase access * Investors with a full data subscription can access data for any fund and any ticker ... Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential …

WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebJun 27, 2024 · CYTK has a market cap of $4.05bn and a cash balance of $686mn. Research and development expenses for the first quarter 2024 were $45.9 million, while general and administrative expenses were $33.1...

WebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · … Web1 day ago · Cytokinetics (CYTK) declines 20% in the year so far as it suffers a regulatory setback for its NDA for omecamtiv mecarbil. 2d ago. Reuters. ... Emerson (ticker: EMR) confirmed Wednesday it was ...

WebApr 20, 2024 · Is CYTK stock a buy? Hedge fund interest in Cytokinetics, Inc. (NASDAQ: CYTK) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that...

WebDec 30, 2024 · Mizuho Securities analyst Salim Syed maintained a Buy rating on Cytokinetics (CYTK - Research Report) today and set a price target of $80.00. The … chromium nitride powder suppliersWebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential … chromium not in programs listWebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, … chromium nitrogen phase diagramWebCytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK financial statements, income statements and financial ratios. chromium noble gas abbreviationWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … chromium normal phasechromium not on task managerWebApr 29, 2004 · Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest funding was raised on Jul 1, 2024 from a Post-IPO Debt round. Cytokinetics is … chromium not showing in control panel